CN1785325A - Ready prepared Chinese medicine for treating acute, chronic prostatitis and its preparation method - Google Patents

Ready prepared Chinese medicine for treating acute, chronic prostatitis and its preparation method Download PDF

Info

Publication number
CN1785325A
CN1785325A CN 200510096360 CN200510096360A CN1785325A CN 1785325 A CN1785325 A CN 1785325A CN 200510096360 CN200510096360 CN 200510096360 CN 200510096360 A CN200510096360 A CN 200510096360A CN 1785325 A CN1785325 A CN 1785325A
Authority
CN
China
Prior art keywords
parts
thick paste
fine powder
add
chinese patent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN 200510096360
Other languages
Chinese (zh)
Other versions
CN100394934C (en
Inventor
胡笑歌
赵宗平
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Xi' An Chiho Pharmaceutical Co ltd
Original Assignee
XIAN QIANHE PHARMACEUTICAL CO Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36782993&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CN1785325(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by XIAN QIANHE PHARMACEUTICAL CO Ltd filed Critical XIAN QIANHE PHARMACEUTICAL CO Ltd
Priority to CNB2005100963607A priority Critical patent/CN100394934C/en
Publication of CN1785325A publication Critical patent/CN1785325A/en
Application granted granted Critical
Publication of CN100394934C publication Critical patent/CN100394934C/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

A Chinese patent medicine for treating acute or chronic prostatitis is prepared from 9 chinese-medicinal materials including red sage root, red peony root, peach kernel, safflower, etc.

Description

Acute and chronic prostatitic Chinese patent medicine of a kind of treatment and preparation method thereof
Technical field
The present invention relates to acute and chronic prostatitic Chinese patent medicine of a kind of treatment and preparation method thereof.
Background technology
Prostatitis is male's commonly encountered diseases, and the overwhelming majority occurs in person between twenty and fifty, and prostatitis can be divided into acute and chronic two kinds clinically.Acute prostatitis is more rare clinically, and chronic prostatitis morbidity in the crowd that grows up is higher, accounts for Urologic Surgery Clinic patient's about 1/5, because of chronic prostatitis many with seminal vesiculitis, so be called prostatovesticulitis again.At present the clinical treatment situation is as follows: 1, the acute prostatitis patient should lie up, general processing such as polydipsia water and relieving constipation.The irritation sign of bladder severe patient can give analgesia spasmolytic medicine and hot water hip-bath with relief of symptoms.Antibacterials can be selected penicillin, streptomycin, ampicillin, cephalosporin and zinacef etc. for use.Acute prostatitis is behind general anti symptom treatment and anti-inflammatory treatment, and symptom often disappears in 1~2 week.Do not feel any better or increase the weight of on the contrary as symptom, the more swelling and fluctuation is arranged of prostate anus digital examination palpation, the visible abscess of ultrasound diagnosis forms, and extracts the pus person out through the perineum puncture, should be through the capable abscess incision and drainage of perineal position.2, chronic prostatitis is mainly taked following measure: massage of prostate, drug infusion, urethral dilatation, prostate periphery seal, antibacterials.All there is certain side effect in above-mentioned Therapeutic Method, and treatment cycle is long, curative effect instability, and general antibacterials are difficult for entering prostata tissue, and this also is one of reason for the treatment of clinically difficulty comparatively.
Summary of the invention
The purpose of this invention is to provide acute and chronic prostatitic Chinese patent medicine of a kind of treatment and preparation method thereof, be used for the acute and chronic prostatitis due to the dampness and heat stasis, without any side effects, easy to use, short treating period, stable curative effect.
Solution of the present invention is based on motherland's medical science to therapeutic prostatitis and pathogenetic understanding of complication and Therapeutic Principle, with reference to the modern pharmacological research achievement, by traditional Chinese medical science prescription theory, skims the cream off milk, and makes its performance clearing away heat-damp and promoting diuresis, the effect of blood-activating analgetic.
Chinese patent medicine of the present invention comprises the crude drug of following component: (consumption is a weight portion)
20~30 parts of 20~30 parts of Radix Paeoniae Rubra of 60~90 parts of Radix Salviae Miltiorrhizaes of Herba Patriniae
20~30 parts of 20~30 parts of Herba Lycopi of 20~30 parts of Flos Carthamis of Semen Persicae
4~6 parts of 20~30 parts of Myrrhas of Folium Pyrrosiae.
In the above-mentioned raw materials medicine, also can add 8~15 parts in 4~6 parts of Olibanums and/or Talcum.
The best component proportioning of Chinese patent medicine of the present invention is: (consumption is a weight portion)
23.4 parts in 23.4 parts of Semen Persicaes of 23.4 parts of Radix Paeoniae Rubra of 70.2 parts of Radix Salviae Miltiorrhizaes of Herba Patriniae
4.7 parts of 23.4 parts of Myrrhas of 23.4 parts of Folium Pyrrosiaes of 23.4 parts of Herba Lycopi of Flos Carthami.
In the above-mentioned raw materials medicine, also can add 11.7 parts in 4.7 parts of Olibanums and/or Talcum.
The preparation method of above-mentioned each component being made Chinese patent medicine of the present invention is:
Myrrha and/or frankincense powder are broken into fine powder, standby; Radix Salviae Miltiorrhizae, Radix Paeoniae Rubra are ground into coarse powder, add 3~7 times of amounts of 95% ethanol, extract secondary, and each 1~3 hour, merge extractive liquid, filtered, and filtrate recycling ethanol also is concentrated into relative density and is determined as 1.32~1.36 thick paste at 60 ℃, and is standby; Medicinal residues after Herba Patriniae, Semen Persicae, Flos Carthami, Herba Lycopi, Folium Pyrrosiae and/or Talcum and the alcohol extraction add 8~12 times of water gagings and decoct secondary, decoct collecting decoction 1~3 hour at every turn, filter, filtrate decompression is concentrated into relative density and is determined as 1.32~1.36 thick paste at 60 ℃, adds the thick paste of Myrrha and/or Olibanum fine powder and ethanol extraction, mixing, dry, be ground into fine powder, add appropriate amount of auxiliary materials, granulate, drying is made capsule.
Get the strong effects for removing toxic heat of Herba Patriniae among the we, the power of Semen Persicae, the pain relieving of Flos Carthami activating blood, resolving stasis, dispelling painful abdominal mass is strong, is monarch drug altogether; Herba Lycopi, Folium Pyrrosiae, Talcum principal drug assistance clearing away heat-damp and promoting diuresis, relieving stranguria by diuresis is a ministerial drug; Radix Salviae Miltiorrhizae, Radix Paeoniae Rubra, Olibanum, Myrrha blood circulation promoting and blood stasis dispelling, promoting the circulation of QI to relieve pain are adjuvant drug.All medicines gather clearing away heat-damp and promoting diuresis altogether, and the function of blood-activating analgetic is subdued the prostatic hyperplasia inflammation, and helping to change of urinating painfully separated.We's characteristic is mainly based on dispersing swelling and dissipating binds, hypertrophy is subdued; it is unobstructed to urinate; Herba Patriniae is as a kind of important heat and toxic materials clearing away medicine; be used for the treatment of various acute infectious disease; especially struvite hypertrophy to be renderd a service and distinguishedly thickened as the rope bar; enclosed mass and tenderness etc. all has better curative effect; compatibility blood circulation promoting and blood stasis dispelling again; the Radix Salviae Miltiorrhizae of reducing swelling and alleviating pain, Radix Paeoniae Rubra, Semen Persicae, Flos Carthami, Olibanum, Myrrha strengthen the merit of its anti-inflammation detumescence, again with the Herba Lycopi, Folium Pyrrosiae; Talcum collateral dredging diuresis is separated also the urinate crime of capable, happy then suffering of patient.
Advantage of the present invention is:
Raising day by day along with modernization of Chinese medicine degree, on the basis of herbal pharmacology and fitochemical studies, pharmaceutically active ingredient or effective site are proved to be definite curative effect and obtain purification in increasing, the present invention arises at the historic moment in this evolution, its scientific and technical content height is modern herbal species, and is without any side effects, easy to use, stable curative effect.
For showing medicine of the present invention to prostatitic therapeutic effect, the present invention is through the clinical observation of 102 routine systems, and prostatitis patient is the male, all meets inclusion criteria, does not have and withdraws from and reject case.At 31 years old~64 years old its age, acute and chronic prostatitis patient is respectively 41 examples, 61 examples.All case all meets the dampness and heat stasis standard.
Instructions of taking: 5 of Chinese patent medicines of the present invention a time, 3 times on the one, treatment time is January.
Therapeutic outcome sees Table 1, table 2.
Table 1 therapeutic outcome
Case load Recovery from illness Produce effects Effectively Invalid Total effective rate (%)
102 37 40 15 10 90.2
Table 2 curative effect and sick relation of planting
The sick kind and case load Recovery from illness Produce effects Effectively Invalid Total effective rate (%)
Acute prostatitis 41 chronic prostatitiss 61 13 23 13 22 9 12 6 4 85.4 93.4
Any toxicity and side effect are not found in the clinical use of 102 routine patients, and liver, kidney merit do not have change before and after the treatment.
In sum, medicine of the present invention has clearing away heat-damp and promoting diuresis, and the effect of blood-activating analgetic has analgesic activity, the reaction that can reduce inflammation, and total effective rate is 90.2%, is worth clinical expansion to use.
Specific embodiment
Embodiment 1
Press column weight amount weighting raw materials (unit: gram)
Herba Patriniae 70.2 Radix Salviae Miltiorrhizaes 23.4 Radix Paeoniae Rubra 23.4 Semen Persicaes 23.4 Flos Carthamis 23.4
Herba Lycopi's 23.4 Folium Pyrrosiaes 23.4 Myrrhas 4.7 Olibanums 4.7.
Preparation method: above-mentioned Myrrha, frankincense powder are broken into fine powder, standby; Radix Salviae Miltiorrhizae, Radix Paeoniae Rubra are ground into coarse powder, add 3~7 times of amounts of 95% ethanol, extract secondary, and each 1~3 hour, merge extractive liquid, filtered, and filtrate recycling ethanol also is concentrated into relative density be 1.32~1.36 thick paste of (60 ℃ time survey), and is standby; Medicinal residues after Herba Patriniae, Semen Persicae, Flos Carthami, Herba Lycopi, Folium Pyrrosiae and the alcohol extraction add 8~12 times of water gagings and decoct secondary, decoct collecting decoction 1~3 hour at every turn, filter, filtrate decompression is concentrated into relative density be 1.32~1.36 thick paste of (60 ℃ time survey), adds Myrrha and the fine powder of Olibanum and the thick paste of ethanol extraction, mixing, dry, be ground into fine powder, add appropriate amount of auxiliary materials, granulate, drying is made capsule.
Embodiment 2
Press column weight amount weighting raw materials (unit: gram)
Herba Patriniae 70.2 Radix Salviae Miltiorrhizaes 23.4 Radix Paeoniae Rubra 23.4 Semen Persicaes 23.4 Flos Carthamis 23.4
Herba Lycopi's 23.4 Folium Pyrrosiaes 23.4 Myrrhas 4.7 Talcums 11.7.
Preparation method: above-mentioned Myrrha is ground into fine powder, standby; Radix Salviae Miltiorrhizae, Radix Paeoniae Rubra are ground into coarse powder, add 3~7 times of amounts of 95% ethanol, extract secondary, and each 1~3 hour, merge extractive liquid, filtered, and filtrate recycling ethanol also is concentrated into relative density be 1.32~1.36 thick paste of (60 ℃ time survey), and is standby; Medicinal residues after Herba Patriniae, Semen Persicae, Flos Carthami, Herba Lycopi, Folium Pyrrosiae, Talcum and the alcohol extraction add 8~12 times of water gagings and decoct secondary, decoct collecting decoction 1~3 hour at every turn, filter, filtrate decompression is concentrated into relative density be 1.32~1.36 thick paste of (60 ℃ time survey), adds the thick paste of Myrrha fine powder and ethanol extraction, mixing, dry, be ground into fine powder, add appropriate amount of auxiliary materials, granulate, drying is made capsule.
Embodiment 3
Press column weight amount weighting raw materials (unit: gram)
Herba Patriniae 70.2 Radix Salviae Miltiorrhizaes 23.4 Radix Paeoniae Rubra 23.4 Semen Persicaes 23.4 Flos Carthamis 23.4
Herba Lycopi's 23.4 Folium Pyrrosiaes 23.4 Myrrhas 4.7 Olibanums 4.7 Talcums 11.7.
Preparation method: above-mentioned Myrrha, frankincense powder are broken into fine powder, standby; Radix Salviae Miltiorrhizae, Radix Paeoniae Rubra are ground into coarse powder, add 3~7 times of amounts of 95% ethanol, extract secondary, and each 1~3 hour, merge extractive liquid, filtered, and filtrate recycling ethanol also is concentrated into relative density be 1.32~1.36 thick paste of (60 ℃ time survey), and is standby; Medicinal residues after Herba Patriniae, Semen Persicae, Flos Carthami, Herba Lycopi, Folium Pyrrosiae, Talcum and the alcohol extraction add 8~12 times of water gagings and decoct secondary, decoct collecting decoction 1~3 hour at every turn, filter, filtrate decompression is concentrated into relative density be 1.32~1.36 thick paste of (60 ℃ time survey), adds Myrrha and the fine powder of Olibanum and the thick paste of ethanol extraction, mixing, dry, be ground into fine powder, add appropriate amount of auxiliary materials, granulate, drying is made capsule.
Embodiment 4
Press column weight amount weighting raw materials (unit: gram)
Herba Patriniae 70.2 Radix Salviae Miltiorrhizaes 23.4 Radix Paeoniae Rubra 23.4 Semen Persicaes 23.4 Flos Carthamis 23.4
Herba Lycopi's 23.4 Folium Pyrrosiaes 23.4 Myrrhas 4.7.
Preparation method: above-mentioned Myrrha is ground into fine powder, standby; Radix Salviae Miltiorrhizae, Radix Paeoniae Rubra are ground into coarse powder, add 3~7 times of amounts of 95% ethanol, extract secondary, and each 1~3 hour, merge extractive liquid, filtered, and filtrate recycling ethanol also is concentrated into relative density be 1.32~1.36 thick paste of (60 ℃ time survey), and is standby; Medicinal residues after Herba Patriniae, Semen Persicae, Flos Carthami, Herba Lycopi, Folium Pyrrosiae and the alcohol extraction add 8~12 times of water gagings and decoct secondary, decoct collecting decoction 1~3 hour at every turn, filter, filtrate decompression is concentrated into relative density be 1.32~1.36 thick paste of (60 ℃ time survey), adds the thick paste of Myrrha fine powder and ethanol extraction, mixing, dry, be ground into fine powder, add appropriate amount of auxiliary materials, granulate, drying is made capsule.
Embodiment 5
Press column weight amount weighting raw materials (unit: gram)
Herba Patriniae 60 Radix Salviae Miltiorrhizaes 20 Radix Paeoniae Rubra 20 Semen Persicaes 20 Flos Carthamis 20
Herba Lycopi's 20 Folium Pyrrosiaes 20 Myrrhas 4 Olibanums 4 Talcums 8.
Preparation method: above-mentioned Myrrha, frankincense powder are broken into fine powder, standby; Radix Salviae Miltiorrhizae, Radix Paeoniae Rubra are ground into coarse powder, add 3~7 times of amounts of 95% ethanol, extract secondary, and each 1~3 hour, merge extractive liquid, filtered, and filtrate recycling ethanol also is concentrated into relative density be 1.32~1.36 thick paste of (60 ℃ time survey), and is standby; Medicinal residues after Herba Patriniae, Semen Persicae, Flos Carthami, Herba Lycopi, Folium Pyrrosiae, Talcum and the alcohol extraction add 8~12 times of water gagings and decoct secondary, decoct collecting decoction 1~3 hour at every turn, filter, filtrate decompression is concentrated into relative density be 1.32~1.36 thick paste of (60 ℃ time survey), adds Myrrha and the fine powder of Olibanum and the thick paste of ethanol extraction, mixing, dry, be ground into fine powder, add appropriate amount of auxiliary materials, granulate, drying is made capsule.
Embodiment 6
Press column weight amount weighting raw materials (unit: gram)
Herba Patriniae 90 Radix Salviae Miltiorrhizaes 30 Radix Paeoniae Rubra 30 Semen Persicaes 30 Flos Carthamis 30
Herba Lycopi's 30 Folium Pyrrosiaes 30 Myrrhas 6 Olibanums 6 Talcums 15.
Preparation method: above-mentioned Myrrha, frankincense powder are broken into fine powder, standby; Radix Salviae Miltiorrhizae, Radix Paeoniae Rubra are ground into coarse powder, add 3~7 times of amounts of 95% ethanol, extract secondary, and each 1~3 hour, merge extractive liquid, filtered, and filtrate recycling ethanol also is concentrated into relative density be 1.32~1.36 thick paste of (60 ℃ time survey), and is standby; Medicinal residues after Herba Patriniae, Semen Persicae, Flos Carthami, Herba Lycopi, Folium Pyrrosiae, Talcum and the alcohol extraction add 8~12 times of water gagings and decoct secondary, decoct collecting decoction 1~3 hour at every turn, filter, filtrate decompression is concentrated into relative density be 1.32~1.36 thick paste of (60 ℃ time survey), adds Myrrha and the fine powder of Olibanum and the thick paste of ethanol extraction, mixing, dry, be ground into fine powder, add appropriate amount of auxiliary materials, granulate, drying is made capsule.
Embodiment 7
Press column weight amount weighting raw materials (unit: jin)
Herba Patriniae 75 Radix Salviae Miltiorrhizaes 25 Radix Paeoniae Rubra 25 Semen Persicaes 25 Flos Carthamis 25
Herba Lycopi's 25 Folium Pyrrosiaes 25 Myrrhas 5 Talcums 10.
Preparation method: above-mentioned Myrrha is ground into fine powder, standby; Radix Salviae Miltiorrhizae, Radix Paeoniae Rubra are ground into coarse powder, add 3~7 times of amounts of 95% ethanol, extract secondary, and each 1~3 hour, merge extractive liquid, filtered, and filtrate recycling ethanol also is concentrated into relative density be 1.32~1.36 thick paste of (60 ℃ time survey), and is standby; Medicinal residues after Herba Patriniae, Semen Persicae, Flos Carthami, Herba Lycopi, Folium Pyrrosiae, Talcum and the alcohol extraction add 8~12 times of water gagings and decoct secondary, decoct collecting decoction 1~3 hour at every turn, filter, filtrate decompression is concentrated into relative density be 1.32~1.36 thick paste of (60 ℃ time survey), adds the thick paste of Myrrha fine powder and ethanol extraction, mixing, dry, be ground into fine powder, add appropriate amount of auxiliary materials, granulate, drying is made capsule.
Embodiment 8
Press column weight amount weighting raw materials (unit: kilogram)
Herba Patriniae 81 Radix Salviae Miltiorrhizaes 27 Radix Paeoniae Rubra 27 Semen Persicaes 27 Flos Carthamis 27
Herba Lycopi's 27 Folium Pyrrosiaes 27 Myrrhas 4.5 Talcums 12.
Preparation method: above-mentioned Myrrha is ground into fine powder, standby; Radix Salviae Miltiorrhizae, Radix Paeoniae Rubra are ground into coarse powder, add 3~7 times of amounts of 95% ethanol, extract secondary, and each 1~3 hour, merge extractive liquid, filtered, and filtrate recycling ethanol also is concentrated into relative density be 1.32~1.36 thick paste of (60 ℃ time survey), and is standby; Medicinal residues after Herba Patriniae, Semen Persicae, Flos Carthami, Herba Lycopi, Folium Pyrrosiae, Talcum and the alcohol extraction add 8~12 times of water gagings and decoct secondary, decoct collecting decoction 1~3 hour at every turn, filter, filtrate decompression is concentrated into relative density be 1.32~1.36 thick paste of (60 ℃ time survey), adds the thick paste of Myrrha fine powder and ethanol extraction, mixing, dry, be ground into fine powder, add appropriate amount of auxiliary materials, granulate, drying is made capsule.
Embodiment 9
Press column weight amount weighting raw materials (unit: kilogram)
Herba Patriniae 78 Radix Salviae Miltiorrhizaes 26 Radix Paeoniae Rubra 26 Semen Persicaes 26 Flos Carthamis 26
Herba Lycopi's 26 Folium Pyrrosiaes 26 Myrrhas 5.4 Olibanums 5.4.
Preparation method: above-mentioned Myrrha and frankincense powder are broken into fine powder, standby; Radix Salviae Miltiorrhizae, Radix Paeoniae Rubra are ground into coarse powder, add 3~7 times of amounts of 95% ethanol, extract secondary, and each 1~3 hour, merge extractive liquid, filtered, and filtrate recycling ethanol also is concentrated into relative density be 1.32~1.36 thick paste of (60 ℃ time survey), and is standby; Medicinal residues after Herba Patriniae, Semen Persicae, Flos Carthami, Herba Lycopi, Folium Pyrrosiae and the alcohol extraction add 8~12 times of water gagings and decoct secondary, decoct collecting decoction 1~3 hour at every turn, filter, filtrate decompression is concentrated into relative density be 1.32~1.36 thick paste of (60 ℃ time survey), adds Myrrha and the fine powder of Olibanum and the thick paste of ethanol extraction, mixing, dry, be ground into fine powder, add appropriate amount of auxiliary materials, granulate, drying is made capsule.
Embodiment 10
Press column weight amount weighting raw materials (unit: kilogram)
Herba Patriniae 66 Radix Salviae Miltiorrhizaes 22 Radix Paeoniae Rubra 22 Semen Persicaes 22 Flos Carthamis 22
Herba Lycopi's 22 Folium Pyrrosiaes 22 Myrrhas 4.5.
Preparation method: above-mentioned Myrrha is ground into fine powder, standby; Radix Salviae Miltiorrhizae, Radix Paeoniae Rubra are ground into coarse powder, add 3~7 times of amounts of 95% ethanol, extract secondary, and each 1~3 hour, merge extractive liquid, filtered, and filtrate recycling ethanol also is concentrated into relative density be 1.32~1.36 thick paste of (60 ℃ time survey), and is standby; Medicinal residues after Herba Patriniae, Semen Persicae, Flos Carthami, Herba Lycopi, Folium Pyrrosiae and the alcohol extraction add 8~12 times of water gagings and decoct secondary, decoct collecting decoction 1~3 hour at every turn, filter, filtrate decompression is concentrated into relative density be 1.32~1.36 thick paste of (60 ℃ time survey), adds the thick paste of Myrrha fine powder and ethanol extraction, mixing, dry, be ground into fine powder, add appropriate amount of auxiliary materials, granulate, drying is made capsule.

Claims (5)

1, the acute and chronic prostatitic Chinese patent medicine of a kind of treatment is characterized in that comprising following bulk drugs:
20~30 parts of 20~30 parts of Radix Paeoniae Rubra of 60~90 parts of Radix Salviae Miltiorrhizaes of Herba Patriniae
20~30 parts of 20~30 parts of Herba Lycopi of 20~30 parts of Flos Carthamis of Semen Persicae
4~6 parts of 20~30 parts of Myrrhas of Folium Pyrrosiae.
2, the acute and chronic prostatitic Chinese patent medicine of treatment as claimed in claim 1 is characterized in that comprising following bulk drugs:
23.4 parts in 23.4 parts of Semen Persicaes of 23.4 parts of Radix Paeoniae Rubra of 70.2 parts of Radix Salviae Miltiorrhizaes of Herba Patriniae
4.7 parts of 23.4 parts of Myrrhas of 23.4 parts of Folium Pyrrosiaes of 23.4 parts of Herba Lycopi of Flos Carthami.
3, the acute and chronic prostatitic Chinese patent medicine of treatment as claimed in claim 1 is characterized in that adding 8~15 parts in 4~6 parts of Olibanums and/or Talcum in described raw material.
4, the acute and chronic prostatitic Chinese patent medicine of treatment as claimed in claim 2 is characterized in that adding 11.7 parts in 4.7 parts of Olibanums and/or Talcum in described raw material.
5, the preparation method as Chinese patent medicine as described in the claim 1,2,3 or 4 is:
Myrrha and/or frankincense powder are broken into fine powder, standby; Radix Salviae Miltiorrhizae, Radix Paeoniae Rubra are ground into coarse powder, add 3~7 times of amounts of 95% ethanol, extract secondary, and each 1~3 hour, merge extractive liquid, filtered, and filtrate recycling ethanol also is concentrated into relative density and is determined as 1.32~1.36 thick paste at 60 ℃, and is standby; Medicinal residues after Herba Patriniae, Semen Persicae, Flos Carthami, Herba Lycopi, Folium Pyrrosiae and/or Talcum and the alcohol extraction add 8~12 times of water gagings and decoct secondary, decoct collecting decoction 1~3 hour at every turn, filter, filtrate decompression is concentrated into relative density and is determined as 1.32~1.36 thick paste at 60 ℃, adds the thick paste of Myrrha and/or Olibanum fine powder and ethanol extraction, mixing, dry, be ground into fine powder, add appropriate amount of auxiliary materials, granulate, drying is made capsule.
CNB2005100963607A 2005-11-17 2005-11-17 Ready prepared Chinese medicine for treating acute, chronic prostatitis and its preparation method Active CN100394934C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNB2005100963607A CN100394934C (en) 2005-11-17 2005-11-17 Ready prepared Chinese medicine for treating acute, chronic prostatitis and its preparation method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNB2005100963607A CN100394934C (en) 2005-11-17 2005-11-17 Ready prepared Chinese medicine for treating acute, chronic prostatitis and its preparation method

Publications (2)

Publication Number Publication Date
CN1785325A true CN1785325A (en) 2006-06-14
CN100394934C CN100394934C (en) 2008-06-18

Family

ID=36782993

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB2005100963607A Active CN100394934C (en) 2005-11-17 2005-11-17 Ready prepared Chinese medicine for treating acute, chronic prostatitis and its preparation method

Country Status (1)

Country Link
CN (1) CN100394934C (en)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101637592B (en) * 2009-07-10 2011-07-13 李小平 Diuresis antibiotic pill
CN102579754A (en) * 2012-02-21 2012-07-18 简福川 Chinese medicament for treating qi stagnation and blood stasis type prostatitis
CN102846759A (en) * 2011-06-27 2013-01-02 西安千禾药业有限责任公司 Pharmaceutical composition for treating acute and chronic prostatitis and preparation method thereof
CN103048416A (en) * 2011-10-14 2013-04-17 西安千禾药业有限责任公司 Detection method of Chinese medicinal composition for treating acute and chronic prostatitis
CN104547123A (en) * 2013-10-16 2015-04-29 西安千禾药业有限责任公司 Preparation method of traditional Chinese medicine composition Qianlieping for treating acute and chronic prostatitis
CN106511631A (en) * 2016-10-25 2017-03-22 西安千禾药业股份有限公司 Qianlieping preparation used for treating prostatitis and preparation method thereof
CN110882313A (en) * 2019-12-09 2020-03-17 西安千禾药业股份有限公司 Medicine for treating irregular menstruation, acute and chronic pelvic inflammatory disease and cervicitis and application thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1090778A (en) * 1993-12-22 1994-08-17 黄海明 " Qianzengshu " medical health bag
CN1054530C (en) * 1996-04-26 2000-07-19 李建平 Qianliehuixiao pill for treating prostatitis and prostatic hyperplasia
CN1478500A (en) * 2002-08-28 2004-03-03 张安学 Adhesive plaster for treating prostatitis

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101637592B (en) * 2009-07-10 2011-07-13 李小平 Diuresis antibiotic pill
CN102846759A (en) * 2011-06-27 2013-01-02 西安千禾药业有限责任公司 Pharmaceutical composition for treating acute and chronic prostatitis and preparation method thereof
CN103048416A (en) * 2011-10-14 2013-04-17 西安千禾药业有限责任公司 Detection method of Chinese medicinal composition for treating acute and chronic prostatitis
CN102579754A (en) * 2012-02-21 2012-07-18 简福川 Chinese medicament for treating qi stagnation and blood stasis type prostatitis
CN104547123A (en) * 2013-10-16 2015-04-29 西安千禾药业有限责任公司 Preparation method of traditional Chinese medicine composition Qianlieping for treating acute and chronic prostatitis
CN104547123B (en) * 2013-10-16 2017-06-30 西安千禾药业有限责任公司 A kind of flat preparation method in Chinese medicine composition prostatitis for treating acute and chronic prostatitis
CN106511631A (en) * 2016-10-25 2017-03-22 西安千禾药业股份有限公司 Qianlieping preparation used for treating prostatitis and preparation method thereof
CN110882313A (en) * 2019-12-09 2020-03-17 西安千禾药业股份有限公司 Medicine for treating irregular menstruation, acute and chronic pelvic inflammatory disease and cervicitis and application thereof
CN110882313B (en) * 2019-12-09 2021-12-21 西安千禾药业股份有限公司 Medicine for treating irregular menstruation, acute and chronic pelvic inflammatory disease and cervicitis and application thereof

Also Published As

Publication number Publication date
CN100394934C (en) 2008-06-18

Similar Documents

Publication Publication Date Title
CN1785325A (en) Ready prepared Chinese medicine for treating acute, chronic prostatitis and its preparation method
CN1739638A (en) Medicine for treating dermatosis and its prepn
CN102058673B (en) Chinese medicine composition for expelling wind and removing dampness and preparation method thereof
CN1742903A (en) Medicine for treating prostatitis and hyperlasia of prostate
CN100344306C (en) Medicine composition for treating urinary system stone and inflammation
CN1927322A (en) Liposoluble traditional medicine bougie for treating acute and chronic prostatitis, and manufacturing technique thereof
CN103705632B (en) The application of BUPIXIAO PIAN in preparation treatment penile induration disease drug
CN1695682A (en) External use preparation for treating rheumatisma and bone injuries
CN1876088A (en) A medicine for treating chronic prostatitis and preparation method thereof
CN1259078C (en) Chinese medicine for treating women's chronic pelvic infection
CN100335083C (en) Pile treating Chinese medicine prepn and its production process
CN1051468C (en) Capsule for curing rheumatism
CN1259943C (en) Prostate hyperplasia pharmaceutical and method for making same
CN1275628C (en) Immediat effect medicinal paste for treating prostatitis
CN1270755C (en) Pharmaceutical composition for treating rheumatic arthritis and rheumatoid arthritis
CN1686414A (en) Wound dispelling swell dispersing tincture and its preparation method
CN1062480C (en) Oral liquor for curing urethritis
CN1086297C (en) A Chinese medicinal pill for treating gynecological diseases
CN1382439A (en) Application of sophocarpidine oxide in preparing medicine to treat ulcerative colitis
CN1548065A (en) Compound Chinese medicine for treating chronic pulvic infection and prepn process of its prepn forms
CN102824573B (en) Medicine for treating prostatic diseases
CN1276761C (en) Compound traditional Chinese and western medicine for treating rheumatism and osteoarthritis and productive method thereof
CN1281239C (en) Chinese medicine composition for treating stone
CN1899390A (en) External use analgesic hemostatic preparation and its preparing method
CN1424104A (en) Medicines for treating chronic prostatitis and preparation thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C56 Change in the name or address of the patentee
CP02 Change in the address of a patent holder

Address after: High tech Zone Zhang Bayi Road 710065 Shaanxi city of Xi'an province No. 1 Huixin IBC-B block 11 layer

Patentee after: XI'AN CHIHO PHARMACEUTICAL Co.,Ltd.

Address before: 710075 Shaanxi city of Xi'an province high tech Industrial Development Zone, high tech Road No. 52 building 17 layer

Patentee before: XI'AN CHIHO PHARMACEUTICAL Co.,Ltd.

C35 Partial or whole invalidation of patent or utility model
IP01 Partial invalidation of patent right

Commission number: 4W101669

Conclusion of examination: The patent continued to be maintained on the basis of the technical scheme and claim 6 of talc, as required in Patent No. 200510096360.7, 3, and 4.

Decision date of declaring invalidation: 20130522

Decision number of declaring invalidation: 20405

Denomination of invention: Ready prepared Chinese medicine for treating acute, chronic prostatitis and its preparation method

Granted publication date: 20080618

Patentee: XI'AN CHIHO PHARMACEUTICAL Co.,Ltd.

CP01 Change in the name or title of a patent holder
CP01 Change in the name or title of a patent holder

Address after: High tech Zone Zhang Bayi Road 710065 Shaanxi city of Xi'an province No. 1 Huixin IBC-B block 11 layer

Patentee after: XI' AN CHIHO PHARMACEUTICAL Co.,Ltd.

Address before: High tech Zone Zhang Bayi Road 710065 Shaanxi city of Xi'an province No. 1 Huixin IBC-B block 11 layer

Patentee before: XI'AN CHIHO PHARMACEUTICAL Co.,Ltd.

IP01 Partial invalidation of patent right
IP01 Partial invalidation of patent right

Commission number: 4W104194

Conclusion of examination: The patent is valid on the basis of the addition of talc in claim No. 200510096360.7, 3, and the technical scheme and claim 4 of talc and frankincense, 6.

Decision date of declaring invalidation: 20160920

Decision number of declaring invalidation: 30074

Denomination of invention: Ready prepared Chinese medicine for treating acute, chronic prostatitis and its preparation method

Granted publication date: 20080618

Patentee: XI' AN CHIHO PHARMACEUTICAL Co.,Ltd.